Literature DB >> 32021017

Survival of osteosarcoma patients following diagnosis of synchronous skip metastases.

Peiming Yang1, Magdalena Gilg1, Scott Evans1, Francesca Totti1, Jonathan Stevenson1, Lee Jeys1, Michael Parry1.   

Abstract

BACKGROUND: We aim to investigate the prognostic implications of synchronous skip metastases in osteosarcoma by presenting the largest single centre series to date.
METHODS: Retrospective study of 21 osteosarcoma patients with skip metastases treated between 1983 and 2004.
RESULTS: No statistical difference in overall survival was demonstrated when comparing presence of lung metastases to those without (p = 0.859). No statistical difference was found in overall survival according to age group (<18yrs vs >18yrs; p = 0.126), or to percentage chemotherapy-induced bone necrosis (<90% vs >90%; p = 0.056).
CONCLUSIONS: The presence of skip metastases confers a very poor prognosis as an independent variable. LEVEL OF EVIDENCE: III.
© 2019 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Osteosarcoma; Skip metastases; Survival; Synchronous

Year:  2019        PMID: 32021017      PMCID: PMC6994740          DOI: 10.1016/j.jor.2019.10.003

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  12 in total

1.  Skip metastasis in osteosarcoma.

Authors:  Patrick J Leavey; Michael D Day; Timothy Booth; Gerhard Maale
Journal:  J Pediatr Hematol Oncol       Date:  2003-10       Impact factor: 1.289

2.  The implications of "skip" metastases in osteosarcoma.

Authors:  W F Enneking; A Kagan
Journal:  Clin Orthop Relat Res       Date:  1975-09       Impact factor: 4.176

3.  Prognosis for patients who have osteosarcoma with skip metastasis.

Authors:  P Wuisman; W F Enneking
Journal:  J Bone Joint Surg Am       Date:  1990-01       Impact factor: 5.284

Review 4.  The accuracy of imaging in the local staging of appendicular osteosarcoma.

Authors:  Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2002-02-09       Impact factor: 2.199

5.  Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group.

Authors:  Leo Kager; Andreas Zoubek; Ulrike Kastner; Beate Kempf-Bielack; Jenny Potratz; Rainer Kotz; G Ulrich Exner; Christiane Franzius; Susanna Lang; Rainer Maas; Heribert Jürgens; Helmut Gadner; Stefan Bielack
Journal:  J Clin Oncol       Date:  2006-04-01       Impact factor: 44.544

6.  Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.

Authors:  Gaetano Bacci; Alessandra Longhi; Michela Versari; Mario Mercuri; Antonio Briccoli; Piero Picci
Journal:  Cancer       Date:  2006-03-01       Impact factor: 6.860

7.  CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: Report of the Radiology Diagnostic Oncology Group.

Authors:  D M Panicek; C Gatsonis; D I Rosenthal; L L Seeger; A G Huvos; S G Moore; D J Caudry; W E Palmer; B J McNeil
Journal:  Radiology       Date:  1997-01       Impact factor: 11.105

8.  Skip metastases in osteosarcoma: recent experience.

Authors:  M M Malawer; W K Dunham
Journal:  J Surg Oncol       Date:  1983-04       Impact factor: 3.454

9.  The incidence and prognosis of osteosarcoma skip metastases.

Authors:  Kaveh R Sajadi; Robert K Heck; Michael D Neel; Bhaskar N Rao; Najat Daw; Carlos Rodriguez-Galindo; Fredric A Hoffer; G Scott Stacy; Terrance D Peabody; Michael A Simon
Journal:  Clin Orthop Relat Res       Date:  2004-09       Impact factor: 4.176

10.  UK Guidelines for the Management of Bone Sarcomas.

Authors:  Robert Grimer; Nick Athanasou; Craig Gerrand; Ian Judson; Ian Lewis; Bruce Morland; David Peake; Beatrice Seddon; Jeremy Whelan
Journal:  Sarcoma       Date:  2010-12-29
View more
  5 in total

1.  A Novel and Effective Model to Predict Skip Metastasis in Papillary Thyroid Carcinoma Based on a Support Vector Machine.

Authors:  Shuting Zhu; Qingxuan Wang; Danni Zheng; Lei Zhu; Zheng Zhou; Shiying Xu; Binbin Shi; Cong Jin; Guowan Zheng; Yefeng Cai
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-05       Impact factor: 6.055

2.  Alternative splicing of leptin receptor overlapping transcript in osteosarcoma.

Authors:  Emel Rothzerg; Xuan D Ho; Jiake Xu; David Wood; Aare Märtson; Katre Maasalu; Sulev Kõks
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-12

3.  Clinical Guideline for Microwave Ablation of Bone Tumors in Extremities.

Authors:  Kai Zheng; Xiuchun Yu; Yongcheng Hu; Yingze Zhang; Zhen Wang; Sujia Wu; Jingnan Shen; Zhaoming Ye; Chongqi Tu; Yu Zhang; Xing Wei; Yong Hu; Xuquan Wang; Jiazhen Li; Hong Duan; Yuxian Wu; Ming Xu; Zhenchao Yuan; Yongzhong Wei; Bingyao Chen
Journal:  Orthop Surg       Date:  2020-08-09       Impact factor: 2.071

4.  Advance MR evaluation of synchronous multifocal osteosarcoma with pathologic fracture.

Authors:  Rosy Setiawati; Eveline Stephanie Lay; Valentina Testini; Paulus Rahardjo; Mouli Edward; Sjahjenny Mustokoweni; Giuseppe Guglielmi
Journal:  BJR Case Rep       Date:  2021-04-15

Review 5.  Metastatic Progression of Osteosarcomas: A Review of Current Knowledge of Environmental versus Oncogenic Drivers.

Authors:  Guillaume Anthony Odri; Joëlle Tchicaya-Bouanga; Diane Ji Yun Yoon; Dominique Modrowski
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.